Daniel Shin is a PharmD with extensive experience in Global Medical Affairs within the pharmaceutical, biotech, and medical device industries. They have demonstrated proficiency in medical review, medical information, medical communications, and scientific engagement, particularly in the therapeutic areas of hematology/oncology, neurology/psychiatry, and rare diseases. Daniel has held various leadership positions at companies such as Novocure, Alexion Pharmaceuticals, and argenx. Currently, they serve as Associate Director of Medical Review at argenx while continuing their education at Rutgers University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices